AMC Entertainment (NYSE:AMC) shares surged 14% Monday, climbing from $1.12 to $1.28 after the company reported a record Easter weekend that drew over 6 million guests to its theaters. It’s the kind of headline…
Palantir Technologies Inc. (NASDAQ:PLTR | PLTR Price Prediction) has been one of the most talked-about AI stocks of the past three years, delivering a 524% gain over five years. Palantir has already given back…
Automatic Data Processing (NASDAQ:ADP | ADP Price Prediction) has fallen sharply, and the fundamentals suggest the market may be mispricing a durable business. If you’re not familiar with ADP, here’s the short version: this…
Tesla (NASDAQ:TSLA | TSLA Price Prediction) has shed nearly 20% year-to-date in 2026 and sits roughly 28% below its December 2025 peak. Our model weighs in on whether this is a buying opportunity or…
Some Wall Street analysts are starting to warn that oil prices could reach levels far above current levels. A perfect storm of supply shocks and rising demand could push oil to $180 per barrel.…
Capital Southwest (NASDAQ:CSWC) pays a 10.6% dividend yield, and that number tends to stop income investors in their tracks. A yield that high on a business development company demands scrutiny, not celebration. The question…
Micron Technology (NASDAQ:MU | MU Price Prediction) stock is up 4% in midday trading on Monday while shares of SanDisk (NASDAQ:SNDK) climb 3%. Both memory chipmakers are riding a wave of renewed enthusiasm around…
Advanced packaging has quietly become the make-or-break factor in the AI race. Hyperscalers need to combine chiplets, high-bandwidth memory, and dense interconnects into powerful final packages that overcome the physical limits of printing ever-larger…
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Coca-Cola (NYSE:KO) both closed out 2025 with Q4 earnings and have raised dividends for 63 consecutive years. But beneath that shared milestone sit two different…
Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two very different pharmaceutical stories. AbbVie is riding a post-Humira reinvention, while Pfizer is still…
It can be an appealing idea to replace your paycheck with passive income. While it sounds exciting on the surface, it is a slightly complicated task. You'll have to work backwards and find out…
I’m a total return guy. All I really care about is after-tax performance with distributions reinvested. I couldn’t care less about how much yield an ETF throws off. Even in retirement, I’d be perfectly…
While High-Yield Savings Accounts (HYSAs) remain a staple for principal preservation due to FDIC and NCUA insurance, the Federal Reserve held its target range at 3.5% to 3.75% at its June 2026 meeting, keeping…
One of the most successful investors, Peter Lynch is known for managing a fund at Fidelity Investments and delivering exceptional results. His investment style encouraged everyday investors to identify companies they understand, and he…
Eli Lilly (NYSE: LLY | LLY Price Prediction) and JPMorgan Chase (NYSE: JPM) both have market caps around $800 billion, putting them in a live race to a $1 trillion market cap. With Lilly…
